ARCHIVES

Vasopermeation Technology Awarded Patent For CA Firm.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012

Letter to the Editors: AACR Defends Policy Paper And Work Of Barker, Sigal.

June 27, 2003

Standard Surgical Protocol Improved Endometrial Staging

October 27, 2006

Axitinib Shows Activity Against Advanced Thyroid Cancer

July 27, 2007

Clinical Trials: Breast Cancer Prevention Trial requires Fewer Participants, NCI Says

September 6, 1996

NCi Advisors Approve New SPORE Grant Program In Cancer Communications.

December 1, 2000